Market Overview

20 Biggest Mid-Day Losers For Thursday

Share:
  • Adeptus Health Inc (NYSE: ADPT) shares dipped 43.4 percent to $3.71 after dropping 2.96 percent on Wednesday.
  • Omega Protein Corporation (NYSE: OME) dropped 20.2 percent to $21.00 after the company posted weak Q4 earnings.
  • Puma Biotechnology Inc (NASDAQ: PBYI) shares declined 19.3 percent to $30.70. Puma Biotechnology reported Q4 adjusted loss of $1.22 per share. Puma Biotechnology also reported the publication of abstracts on neratinib for the AACR Annual Meeting 2017
  • PTC Therapeutics, Inc. (NASDAQ: PTCT) shares tumbled 15.8 percent to $11.10 after the company disclosed that Ataluren Confirmatory Trial missed primary and secondary endpoints.
  • Endeavour Silver Corp (NYSE: EXK) fell 14.4 percent to $3.76. Endeavour Silver reported a Q4 loss of $5.2 million.
  • Vectrus Inc (NYSE: VEC) dropped 12.7 percent to $21.62 on weak quarterly earnings.
  • Greif, Inc. (NYSE: GEF) shares slipped 12.7 percent to $52.63 after the company posted downbeat Q1 earnings.
  • ANI Pharmaceuticals Inc (NASDAQ: ANIP) shares declined 12.4 percent to $52.39. ANI Pharmaceuticals reported a Q4 loss of $1.1 million on revenue of $38.2 million.
  • AXT Inc (NASDAQ: AXTI) dropped 11.6 percent to $6.63. AXT priced 4.6 million shares at $6.50 per share.
  • Health Insurance Innovations Inc (NASDAQ: HIIQ) shares fell 11.5 percent to $15.80. Health Insurance Innovations reported a Q4 loss of $200,000.
  • Ashford Hospitality Prime Inc (NYSE: AHP) shares dropped 10.1 percent to $11.60. Ashford Prime reported a 1.15 million share offering of common stock and announced plans to acquire Hotel Yountville for $96.5 million.
  • Ares Management LP (NYSE: ARES) declined 10 percent to $19.80. Ares Management reported the launch of 7.5 million unit secondary offering.
  • HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares slipped 9.7 percent to $2.86 after rising 16.12 percent on Wednesday.
  • Opko Health Inc. (NASDAQ: OPK) shares dropped 9.7 percent to $7.55. OPKO Health reported a Q4 loss of $0.04 per share on revenue of $275.5 million.
  • TICC Capital Corp. (NASDAQ: TICC) fell 9.5 percent to $7.14. TICC reported net investment income of $0.14 per share for the quarter ended December 31, 2016.
  • Kratos Defense & Security Solutions, Inc (NASDAQ: KTOS) declined 8.2 percent to $7.37 after reporting a proposed public offering of common stock.
  • Stage Stores Inc (NYSE: SSI) declined 6 percent to $2.18 after the company reported weaker-than-expected earnings for its fourth quarter and issued a downbeat forecast for FY 2017.
  • Juno Therapeutics Inc (NASDAQ: JUNO) slipped 4.8 percent to $24.10. Juno Therapeutics reported a Q4 loss of $0.51 per share on revenue of $21.153 million. Juno also announced plans to end development of its cancer drug.
  • Kite Pharma Inc (NASDAQ: KITE) fell 4.8 percent to $75.79. Kite reported commencement of 4.75 million share offering. Citigroup downgraded Kite Pharma from Buy to Neutral.
  • Anheuser Busch Inbev NV (ADR) (NYSE: BUD) fell 2.7 percent to $106.99 on weak quarterly earnings. Bank of America downgraded Anheuser-Busch Inbev from Buy to Neutral.

Latest Ratings for ADPT

DateFirmActionFromTo
Nov 2020Morgan StanleyMaintainsEqual-Weight
Sep 2020Morgan StanleyInitiates Coverage OnEqual-Weight
May 2020GuggenheimMaintainsBuy

View More Analyst Ratings for ADPT
View the Latest Analyst Ratings

 

Related Articles (OME + ADPT)

View Comments and Join the Discussion!

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

Latest Ratings

StockFirmActionPT
MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
NVDASusquehannaMaintains625.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com